Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00861328
Recruitment Status : Completed
First Posted : March 13, 2009
Last Update Posted : June 23, 2017
Information provided by (Responsible Party):
Onconova Therapeutics, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2011
  Study Completion Date : July 2011
Publications of Results:
Garcia-Manero G, Fenaux P. Comprehensive Analysis of Safety: Rigosertib in 557 Patients with Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML). Blood Dec 2016, 128 (22) 2011; ASH 2016.

Other Publications: